Last reviewed · How we verify
NCT05750537: EMPACT-Us
Enhanced Multicomponent Proactive Navigator-Assisted Cessation of Tobacco Use in Low-Income Patients
NA trial testing EMPACT-Us in Tobacco Use Cessation in 13,496 participants. Status unknown.
30 June 2025
Quick facts
| Lead sponsor | Family Health Centers of San Diego |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 13,496 |
| Start date | 27 February 2023 |
| Primary completion | 30 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- EMPACT-Us
Conditions studied
- Tobacco Use Cessation — all drugs for Tobacco Use Cessation →
Sponsor
Family Health Centers of San Diego
Who can join
18 and older, any sex, with Tobacco Use Cessation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study is being conducted to test the effectiveness of the Enhanced Multicomponent Proactive Navigator-Assisted Cessation of Tobacco Use (EMPACT-Us), an innovative suite of tobacco cessation services designed in partnership with patients, providers, and other community stakeholders during a pilot study. We hypothesize that EMPACT-Us will be more effective than the newly-enhanced usual care on improving engagement in tobacco treatments, quit attempts and biochemically verified cessation at 6-and 12-months post initial offerings.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Assessing the effects of Enhanced Multicomponent Proactive Navigator-Assisted Cessation of Tobacco Use within a federally qualified health center (EMPACT-Us): a protocol study.
Ramirez GF, Badii NZ, Mohn P, Northrup A, et al · · 2024 · PMID 39695566 · DOI 10.1186/s12889-024-20997-6
Verify or expand the search:
- PubMed search for NCT05750537
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tobacco Use Cessation
Currently open trials in the same condition.
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
- NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness · Phase 4 · recruiting
- NCT07020273 — CONNECT Cancer Survivors With Tobacco Treatment · NA · recruiting
- NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
- NCT06881069 — Reach Through Equitable Implementation in Utah · NA · recruiting
Other Family Health Centers of San Diego trials
Trials by the same sponsor.
- NCT05167227 — Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing · NA · active not recruiting
- NCT04741750 — Increasing HCV Linkage to Care Among People Who Inject Drugs · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05750537 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Family Health Centers of San Diego
- Last refreshed: 7 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05750537.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing